StockNews.com assumed coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research report released on Wednesday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock.
Cumberland Pharmaceuticals Price Performance
Shares of NASDAQ CPIX opened at $1.27 on Wednesday. The firm has a market capitalization of $18.02 million, a P/E ratio of -2.15 and a beta of 0.20. The company has a quick ratio of 1.26, a current ratio of 1.44 and a debt-to-equity ratio of 0.62. The stock’s 50-day simple moving average is $1.33 and its two-hundred day simple moving average is $1.48. Cumberland Pharmaceuticals has a twelve month low of $1.20 and a twelve month high of $2.36.
About Cumberland Pharmaceuticals
Further Reading
- Five stocks we like better than Cumberland Pharmaceuticals
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Momentum Trades for October With Ample Upside Ahead
- How to invest in marijuana stocks in 7 steps
- Roblox Dips on Short Report—Here’s Why It Could Bounce Back Fast
- Roth IRA Calculator: Calculate Your Potential Returns
- 2 Reasons to Jump on Apple Stock Now and 1 Reason to Think Twice
Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.